Advances in Oncogene-Driven Metastatic NSCLC: Focusing on EFGR Exon 20 Insertions and ALK-Positive NSCLC

Prof Perol summarizes the key information from Medscape’s live symposium on EGFR exon 20 insertions and ALK-positive NSCLC. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/950660?src=mkm_podcast_addon_950660